Three endpoints of in vivo tumour radiobiology and their statistical estimation
about
RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancerInhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma.Intracellular delivery system for antibody-Peptide drug conjugatesComparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in MiceAssessment of antitumor activity for tumor xenograft studies using exponential growth modelsStrategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer.Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers.Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer.Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer.Preclinical mouse solid tumour models: status quo, challenges and perspectives.
P2860
Q30365298-E6DFDF88-A5CF-4C58-B83B-5144B8F08A94Q33591690-AA66D3E6-EB03-467B-A05E-209C843F5979Q34777845-3482B0FB-FCA2-4A00-9B8A-B678D82CBE4AQ35537599-D34AFEFC-36E9-40F2-AB9D-E336FACB41B2Q35594851-2C64D70C-F64D-486D-A8B1-856ACE07F95AQ36048258-41A9AF6F-16A3-4D5B-BC3E-CE99B354C399Q36345349-518DA938-29D1-4F79-B94D-ABE1B3D46CD9Q36863266-E133E7FA-F5F2-4DB1-B0AB-440054CCD44EQ40009198-0F9D33B3-C1BC-4DBF-9535-F73DD9F57478Q41512813-63CEA997-E753-4E72-9A2A-375A316E9FC9Q47414919-49DAB65E-7B42-4896-94C2-5ADB0769E0AEQ50048638-3BE76A99-E1E5-4C75-A27A-F017FF08E0CEQ50096902-598CDBFA-A332-4928-A52B-40EACBE66FE3
P2860
Three endpoints of in vivo tumour radiobiology and their statistical estimation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Three endpoints of in vivo tumour radiobiology and their statistical estimation
@en
Three endpoints of in vivo tumour radiobiology and their statistical estimation.
@nl
type
label
Three endpoints of in vivo tumour radiobiology and their statistical estimation
@en
Three endpoints of in vivo tumour radiobiology and their statistical estimation.
@nl
prefLabel
Three endpoints of in vivo tumour radiobiology and their statistical estimation
@en
Three endpoints of in vivo tumour radiobiology and their statistical estimation.
@nl
P2860
P1476
Three endpoints of in vivo tumour radiobiology and their statistical estimation
@en
P2093
Eugene Demidenko
P2860
P304
P356
10.3109/09553000903419304
P577
2010-02-01T00:00:00Z